Participating Faculty: The Evidence for Semaglutide 2.4 mg in Obesity From a Managed Care Perspective

Faculty

Anastassia Amaro, MD

Associate Professor of Clinical Medicine

Division of Endocrinology, Diabetes and Metabolism

Medical Director

Penn Metabolic Medicine

University of Pennsylvania

Philadelphia, PA

Marc-André Cornier, MD

Director and Professor of Medicine

Division of Endocrinology, Diabetes and Metabolic Diseases

Medical University of South Carolina

Charleston, SC

Michael Kaplan, DO

Associate Clinical Professor

Division of Internal Medicine

Division of Preventative Medicine

Stony Brook University Hospital

Stony Brook, NY

Janine Kyrillos, MD

Medical Director

Comprehensive Weight Management

Jefferson Health

Associate Professor of Clinical Medicine

Department of Medicine

Sidney Kimmel Medical College at Thomas Jefferson University

Philadelphia, PA

Ethan Lazarus, MD

Owner and Physician

Clinical Nutrition Center

Greenwood Village, CO

Senior Clinical Instructor

University of Colorado Anschutz Medical Campus

Denver, CO

Danielle C. Massie, PharmD

Manager, Business Development

Clinical Pharmacy

Moda Health

Portland, OR

Shiara Ortiz-Pujols, MD, MPH

Medical Director of Obesity Medicine

MedExpress/Optum Health Services

Minneapolis, MN

Faculty Disclosures

These faculty have disclosed the following relevant commercial financial relationships or affiliations in the past 12 months.

Anastassia Amaro, MD

CONSULTANCIES OR PAID ADVISORY BOARDS

Novo Nordisk

GRANTS RECEIVED

Altimmune, Eli Lilly

Marc-André Cornier, MD

CONSULTANCIES OR PAID ADVISORY BOARDS

Novo Nordisk

Michael Kaplan, DO

HONORARIA

Novo Nordisk

Janine Kyrillos, MD

PAID ADVISORY BOARD

Lilly

LECTURE FEES

Novo Nordisk

Ethan Lazarus, MD

BOARD MEMBERSHIP

Obesity Medicine Association

CONSULTANCIES OR PAID ADVISORY BOARDS

Currax Pharmaceuticals, Nestle Health Sciences

HONORARIA

Currax Pharmaceuticals, Nestle Health Sciences, Novo Nordisk, Obesity Medicine Association

LECTURE FEES

Currax Pharmaceuticals, Novo Nordisk

Danielle C. Massie, PharmD, and Shiara Ortiz-Pujols, MD, MPH, have nothing to disclose.